Graham Lewis

Profile

Biography

• PhD (Manchester)
• MSc (Aston)
• BA (York)

Research

Overview

• Sociology of science and technology
• Science and technology policy
• Pharmacogenetics and related genetics-based technologies
• Innovation and regulation of medicinal products

Graham's main research interests are in the area of risk and the social control of new technologies, focusing on the development and regulation of medicinal products. Since joining SATSU in 2001, his interests have concentrated on the regulatory, social, and ethical aspects of pharmacogenetics and related gene-based therapeutic models. A related interest is the analysis of biobanking practices, with an emphasis on social and regulatory issues.

Publications

Selected publications

• Martin P, Lewis G, Smart A, and Webster A (2006) False Promise? Prospects for the Clinical and Commercial Development of Pharmacogenetics, University of Nottingham/University of York (ISBN: 0-9553542-1-8).
• Hedgecoe A, Corrigan O, Hogarth, S, Hopkins M, Lewis G, Martin P and Melzer, D (2006) Policy Issues in Pharmacogenetics: Policy Briefing from the UK Pharmacogenetics Study Group (July)
• Hopkins, MM, Ibarreta D, Gaisser S, Enzing CM, Ryan J, Martin PA, Lewis G, Det-mar S, van den Akker MS, Hedgecoe AM, Nightingale P, Dreiling M, Hartig KJ, Vullings W & Forde T (2006) Putting pharmacogenetics into practice, Nature Biotechnology 24(3) 403-410.
• Hopkins, MM, Lewis G, Gaisser S, Ryan J, Enzing C, Hartig J, Vullings W, and Forde T, Regulatory and quality assurance frameworks for PGx: A comparative study of the US, EU and four EU member states. Part 3 of An ESTO study on Pharmacogenetics and Pharmacogenomics: State of the art and social and eco-nomic impacts (2006), Institute for Prospective Technological Studies (IPTS)/European Science and Technology Observatory (ESTO)/European Commission. Available here
• A. Webster, P Martin, G Lewis and A Smart (2004) Integrating pharmacogenetics into society: in search of a model, Nature Reviews Genetics, 5:7-13.
• Munir Pirmohamed and Graham Lewis (2004). Implications of Pharmacogenetics and Pharmacogenomics for Drug Development and Health Care, in: Elias Mossialos, Monique Mrazek & Tom Walley (eds), Regulating Pharmaceuticals in Europe: Striving For Efficiency, Equity and Quality, London: European Observatory on Health Care Systems/Open University Press.
• Graham Lewis (2004) Tissue collection and the pharmaceutical industry: investigating corporate biobanks, in R Tutton and O. Corrigan (eds), Genetic Databases: Socio-ethical Issues in the Collection and Use of DNA, London: Palgrave